1-20 of 3,356 results for member:"Baroness Cumberlege"
Librarians' tools
- Search time
- 0.486 seconds
- Solr query time
- 0.008 seconds
- Search query
- member:"Baroness Cumberlege"
- We searched for
- member_ses:299968
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
My Lords, it gives me great pleasure to follow the noble Baroness’s interesting speech, for which I thank her.
Farming should be a really important subject of concern. In this country, we are 50% reliant on food from abroad. The Government may well stock vaccines for pandemics, increase GP numbers and...
My Lords, it gives me great pleasure to follow the noble Baroness’s interesting speech, for which I thank her.
Farming should be a really important subject of concern. In this country, we are 50% reliant on food from abroad. The Government may well stock vaccines for pandemics, increase GP numbers and...
To ask His Majesty's Government why there is disparity in the legal prescribing rights of various professions when nurses, pharmacists, physiotherapists, podiatrists, therapeutic and diagnostic radiographers, dietitians and paramedics all undertake prescribing training together, and are assessed in the same way.
To ask His Majesty's Government why there is disparity in the legal prescribing rights of various professions when nurses, pharmacists, physiotherapists, podiatrists, therapeutic and diagnostic radiographers, dietitians and paramedics all undertake prescribing training together, and are assessed in the same way.
Non-medical prescribers must work within their own level of expertise. This, together with the requirements of the roles in which different professions are employed, is reflected in the differences between the legal prescribing responsibilities of these professions. Regulators keep records of which healthcare professionals can prescribe, and employers have a responsibility to ensure that non-medical prescribers undertake the relevant training and development, so that their knowledge and skills remain up to date. This is to ensure clinicians work within their sphere of competence.
To ask His Majesty's Government when they will respond to the report by the Patient Safety Commissioner The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February.
To ask His Majesty's Government when they will respond to the report by the Patient Safety Commissioner The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February.
The Government is carefully considering the valuable work done by the Patient Safety commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. We will be providing an update to the Patient Safety Commissioner’s Report at the earliest opportunity.
Lords question for short debate on what progress they have made in ensuring that those who have suffered complications following vaginal mesh implants receive financial compensation.
Lords question for short debate on what progress they have made in ensuring that those who have suffered complications following vaginal mesh implants receive financial compensation.
My Lords, I am grateful to all noble Lords who have decided to speak in this short debate. I thank them for taking part and look forward to their contributions, as well as to the Minister’s reply. This is a subject that I feel very passionate about, and I welcome...
My Lords, I am grateful to all noble Lords who have decided to speak in this short debate. I thank them for taking part and look forward to their contributions, as well as to the Minister’s reply. This is a subject that I feel very passionate about, and I welcome...
My Lords, does my noble friend share my view about the evidence that, when midwives and other clinical staff understand the importance of continuity, it leads to safer care and better outcomes for both the mother and the baby?
One of the midwives quoted in chapter 2 of the report that was sent to us—I thank my noble friend for that—says that working in a continuity team was the best, most rewarding time in their career. Continuity is absolutely critical; it comes up in a number of reports, some of which I have had a part in writing. We know that you need continuity if you are going to make a real impression on the midwifery service and that the women who are party to it must really understand what continuity does and can achieve.
My Lords, does my noble friend share my view about the evidence that, when midwives and other clinical staff understand the importance of continuity, it leads to safer care and better outcomes for both the mother and the baby?
One of the midwives quoted in chapter 2 of the report that was sent to us—I thank my noble friend for that—says that working in a continuity team was the best, most rewarding time in their career. Continuity is absolutely critical; it comes up in a number of reports, some of which I have had a part in writing. We know that you need continuity if you are going to make a real impression on the midwifery service and that the women who are party to it must really understand what continuity does and can achieve.
I thank my noble friend, who has been a tireless campaigner on continuity of care. I challenged the chief midwife on this just this morning, and the objective behind the long-term workforce plan is to make sure that we have the resources in place to maintain that, starting with ethnic minorities. We all know that there is a disparity of outcomes in terms of inequality, so the first priority for continuity of care is that setting, but the objective is to spread that across the whole system.
My Lords, I thank my noble friend for that reassuring reply. However, as it has been five months since the Government received the advice from the Patient Safety Commissioner in October 2023, how much more time do patients and families need to wait for the redress that they so desperately need?
My Lords, I thank my noble friend for that reassuring reply. However, as it has been five months since the Government received the advice from the Patient Safety Commissioner in October 2023, how much more time do patients and families need to wait for the redress that they so desperately need?
My Lords, I thank my noble friend for her tireless work in this area. It is something which, in the Chancellor’s very own words—because it was the Chancellor who, as Health Secretary, first commissioned the report—remains a top priority to both him and the Government. That remains the case.
I spoke to Minister Caulfield about it just this morning, and it is a complicated area, but it is something that we are very keen to redress in the next few months.
To ask His Majesty’s Government what are the timescales for, and what progress has been made on, a response to the Patient Safety Commissioner’s report on options for redress for those harmed by sodium valproate and pelvic mesh, published on 7 February.
To ask His Majesty’s Government what are the timescales for, and what progress has been made on, a response to the Patient Safety Commissioner’s report on options for redress for those harmed by sodium valproate and pelvic mesh, published on 7 February.
The Government commissioned the Patient Safety Commissioner to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the commissioner and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government are now carefully considering the PSC’s recommendations and will respond substantively, hopefully in the coming months.
My Lords, it gives me great pleasure to follow the noble Baroness, Lady Taylor of Bolton, and thank her for a very interesting and incisive speech. I see that congratulations are being offered to her right now and she deserves them.
One thing that struck me as the noble Baroness was...
My Lords, it gives me great pleasure to follow the noble Baroness, Lady Taylor of Bolton, and thank her for a very interesting and incisive speech. I see that congratulations are being offered to her right now and she deserves them.
One thing that struck me as the noble Baroness was...
My Lords, does my noble friend the Minister agree that, in this technological age, it is very important that people are able to access everything they need from the NHS via their phone or a laptop? I am working to ensure that all women have access to their maternity record via the NHS app, but only 23% of sexual health clinics currently allow online booking. Can my noble friend tell me how the Government plan to address this issue?
My Lords, does my noble friend the Minister agree that, in this technological age, it is very important that people are able to access everything they need from the NHS via their phone or a laptop? I am working to ensure that all women have access to their maternity record via the NHS app, but only 23% of sexual health clinics currently allow online booking. Can my noble friend tell me how the Government plan to address this issue?
I thank my noble friend. As she knows, I am a big advocate of everything that we can do with the app. We are absolutely looking to extend its services, which will include sexual health clinics. In the past year alone, we have increased from around 10% of GPs allowing someone to see their records to around 70% today. Sexual health clinics are clearly an area that we need to look at next.
My Lords, it is a great pleasure for me to follow Sarah Mullally, the right reverend Prelate the Bishop of London. She has a very interesting—I was going to say “past” but I think they call it a “back story” today. She has done a huge amount in the National...
My Lords, it is a great pleasure for me to follow Sarah Mullally, the right reverend Prelate the Bishop of London. She has a very interesting—I was going to say “past” but I think they call it a “back story” today. She has done a huge amount in the National...
To ask His Majesty's Government what steps they are taking to protect patients from (1) unregulated, and (2) unqualified, non-medical ultrasound practitioners.
To ask His Majesty's Government what steps they are taking to protect patients from (1) unregulated, and (2) unqualified, non-medical ultrasound practitioners.
The Government is clear that the regulatory oversight of health and care professions must be proportionate to the risks to the public. Statutory regulation of healthcare professionals should only be used where the risks to patient protection cannot be addressed through employer oversight, system regulation, or accredited voluntary registration.
Services offering diagnostic and screening procedures that use ultrasound to examine the body must register with the Care Quality Commission (CQC). Providers must demonstrate that they provide enough suitably qualified, competent, skilled, and experienced staff to meet the needs of the people using the service to comply with the CQC’s regulatory requirements to operate.
Some sonographers are qualified and registered to practice in another healthcare profession that is subject to statutory regulation. The Professional Standards Authority for Health and Social Care manages the Accredited Registers Programme which independently assesses organisations who operate voluntary registers for practitioners who are not regulated by law. Sonographers can register with the accredited Register of Clinical Technologists.
The Government keeps the healthcare professions subject to statutory regulation under review and recently ran a consultation seeking views on the criteria used to decide when regulation is necessary, and whether there are any unregulated professions that should be brought into statutory regulation. The Government will publish its response to the consultation in due course.
To ask His Majesty's Government what safeguards they have in place to ensure high quality and precise data are entered into the medical devices outcomes register.
To ask His Majesty's Government what safeguards they have in place to ensure high quality and precise data are entered into the medical devices outcomes register.
The Medical Device Outcome Registry (MDOR) will significantly improve the quality of data available to improve patient safety and outcomes in high-risk medical device procedures.
NHS England will monitor data quality in the MDOR via regular audits and feedback reports so they can make improvements and provide additional support where required. They are also expanding upon the Data Quality provider certification and award scheme currently active in the National Joint Registry. This is with a view to covering all registry procedures with a particular emphasis on collecting data on medical devices and consultants, Patient Reported Outcome Measures and patient feedback indicators. NHS England have mandated registry submission and will be monitoring compliance and ascertainment against Secondary Uses Service procedure data, to resolve any data completeness or quality issues.
MDOR has native barcode scanning, including Unique Device Identifier (UDI) barcodes, so will result in the whole of England having an available UDI scanning solution without having to implement a separate system. The registry will accept bulk uploads from existing providers’ solutions, including Scan4Safety, that meet the data quality and completeness requirements. The Outcomes and Registries programme will support provider adoption of digital solutions that enable medical device traceability on the electronic patient record. The aim is to have full data submission by NHS England and independent sector providers by the end of the year.
NHS England will be working with various Scan4Safety programme initiatives across England and the four nations, focussing upon medical device traceability and device-based procedures to enable scanning of device data into the patient record.
To ask His Majesty's Government what plans they have, and over what timescale, to further implement Scan4Safety and increase the percentage of NHS Trusts scanning products at the point of care.
To ask His Majesty's Government what plans they have, and over what timescale, to further implement Scan4Safety and increase the percentage of NHS Trusts scanning products at the point of care.
The Medical Device Outcome Registry (MDOR) will significantly improve the quality of data available to improve patient safety and outcomes in high-risk medical device procedures.
NHS England will monitor data quality in the MDOR via regular audits and feedback reports so they can make improvements and provide additional support where required. They are also expanding upon the Data Quality provider certification and award scheme currently active in the National Joint Registry. This is with a view to covering all registry procedures with a particular emphasis on collecting data on medical devices and consultants, Patient Reported Outcome Measures and patient feedback indicators. NHS England have mandated registry submission and will be monitoring compliance and ascertainment against Secondary Uses Service procedure data, to resolve any data completeness or quality issues.
MDOR has native barcode scanning, including Unique Device Identifier (UDI) barcodes, so will result in the whole of England having an available UDI scanning solution without having to implement a separate system. The registry will accept bulk uploads from existing providers’ solutions, including Scan4Safety, that meet the data quality and completeness requirements. The Outcomes and Registries programme will support provider adoption of digital solutions that enable medical device traceability on the electronic patient record. The aim is to have full data submission by NHS England and independent sector providers by the end of the year.
NHS England will be working with various Scan4Safety programme initiatives across England and the four nations, focussing upon medical device traceability and device-based procedures to enable scanning of device data into the patient record.
My Lords, I thank my noble friend for that Answer. It goes some way, I think, to reassure many of us who have been very concerned about sodium valproate being given to pregnant women, and the result that that has had. I am seeking to ensure that, with the plain boxes which contain sodium valproate, those tablets are not actually opened without a clear warning, so that people know exactly what is contained in those boxes and the harmful effects it could have on their babies. Can the Minister tell me what is actually happening to those plain boxes, because sodium valproate should not be prescribed without a really clear warning about what it could do to babies and women?
My Lords, I thank my noble friend for that Answer. It goes some way, I think, to reassure many of us who have been very concerned about sodium valproate being given to pregnant women, and the result that that has had. I am seeking to ensure that, with the plain boxes which contain sodium valproate, those tablets are not actually opened without a clear warning, so that people know exactly what is contained in those boxes and the harmful effects it could have on their babies. Can the Minister tell me what is actually happening to those plain boxes, because sodium valproate should not be prescribed without a really clear warning about what it could do to babies and women?
First, I thank my noble friend for all the vital work that she has done in this space. She is absolutely correct. The key thing is that there are circumstances where sodium valproate is the only effective treatment for bipolar and epilepsy-type disease problems. However, we have to ensure that if people are taking it, they are going into it with their eyes completely open, so that they fully understand the risks. That is absolutely to do with the packaging. It is also about making sure that if that packaging is split up there are leaflets in every part, and that everyone signs a consent form at least once a year, fully acknowledging the risks. Thereby, if people take the treatment, they are doing so with their eyes fully open.
To ask His Majesty’s Government what further steps they are taking to protect patients and families from the harmful effects of sodium valproate taken during pregnancy, and what is their timetable for doing so.
To ask His Majesty’s Government what further steps they are taking to protect patients and families from the harmful effects of sodium valproate taken during pregnancy, and what is their timetable for doing so.
Our aim is to reduce and finally eliminate the harms of valproate in pregnancy. In December, we announced additional measures to protect women and families through a requirement for two prescribers, further warnings in the valproate product information, and improved educational materials. No woman of childbearing potential should receive valproate unless no other treatment
is effective or tolerated. Implementation plans are now being finalised, with engagement with healthcare and patient organisations.
My Lords, my noble friend will be aware that for many years, the UK has enjoyed increases in life expectancy but now we are getting reports that the rate of increase is declining. What plans—I have given my noble friend notice of this question—do the Government have to reverse this trend?
My Lords, my noble friend will be aware that for many years, the UK has enjoyed increases in life expectancy but now we are getting reports that the rate of increase is declining. What plans—I have given my noble friend notice of this question—do the Government have to reverse this trend?
My noble friend, whom I thank for that question, has characterised this issue in exactly the right way. Life expectancy is still increasing, but not at the rate it was. That is why the major conditions strategy was launched. I can give one example: cancer is one of the six major killers, and we are seeing 20% more cancer patients this year than we were pre-pandemic. So there are improvements in this space, and that is what the major conditions strategy is all about; but clearly, the record investment we are putting in needs to show that sort of output.
To ask His Majesty's Government, further to the remarks by Lord Evans of Rainow on 20 March (HL Deb col 1529), what is the source of their data for saying that six percent of GP services could be provided by pharmacies; and what is the evidence base for those data.
To ask His Majesty's Government, further to the remarks by Lord Evans of Rainow on 20 March (HL Deb col 1529), what is the source of their data for saying that six percent of GP services could be provided by pharmacies; and what is the evidence base for those data.
The source of the data that 6% of general practitioner (GP) services could be provided by pharmacies, as referenced by Lord Evans of Rainow on 20 March, is the report Making Time in General Practice, published by the Primary Care Foundation and NHS Alliance in October 2015. This research found that 5.5% of GP appointments were potentially avoidable by being directed instead to self-care/pharmacy. These findings were referenced in the later report General Practice Forward View, published by NHS England in April 2016. In this report the figure was rounded to 6%.
Copies of both reports are attached.
Tabled by
Baroness Cumberlege
To ask His Majesty’s Government what plans they have for making the best use of community pharmacies.
Tabled by
Baroness Cumberlege
To ask His Majesty’s Government what plans they have for making the best use of community pharmacies.
My Lords, community pharmacies make a vital contribution to the provision of primary care. The Government and the sector continue to implement their vision, agreed in 2019, to make better use of the skills and expertise of community pharmacy teams. This aims to develop the role of community pharmacy in managing demand for urgent care, supporting optimal use of medicines and prevention and detection services. We continue to explore what else community pharmacy could be commissioned to do.
My Lords, it is a great challenge to follow the inspiration of the right reverend Prelate the Bishop of London. We can easily see why she is the Bishop of London. I thank her for a marvellous talk.
The right reverend Prelate challenged nurses to take on bigger, more important roles....
My Lords, it is a great challenge to follow the inspiration of the right reverend Prelate the Bishop of London. We can easily see why she is the Bishop of London. I thank her for a marvellous talk.
The right reverend Prelate challenged nurses to take on bigger, more important roles....